NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on April 15, 2026, it issued inducement awards to two recently hired employees in accor ...

LEXINGTON, Ky. (WKYT) - The Lexington Fire Department has released structure fire call data covering the first two months of 2026. Battalion Chief Derek Roberts provided numbers on both total ...

The Senate’s CLARITY Act would explicitly classify XRP as a non-security, removing years of legal uncertainty that kept institutional investors on the sidelines. The CLARITY Act stalled on January 15 ...

This important study presents the rational redesign and engineering of interleukin-7. The data from the integrated approach of using computational, biophysical, and cellular experiments are convincing ...

Natural immunity is emerging as an important mediator of protection from atherogenesis. Natural IgM antibodies that recognize oxidation-specific epitopes on low-density lipoprotein or phospholipids ...

ABSTRACT: Allergic conjunctivitis (AC) is a common ocular surface allergic disease with a rising global incidence, significantly impacting patients’ quality of life. Traditional diagnosis primarily ...

Please provide your email address to receive an email when new articles are posted on . The interleukin-5 inhibitor benralizumab yielded durable remission rates in EGPA. The drug showed no new safety ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...

Just two of the nine shoes leading Nike’s reorganized running lineup have yet to release. Both of those come from the Structure franchise, and one has been confirmed for an early 2026 release. The ...